Biotheus’ antibody drug targets PD-L1 and VEGF, a design that’s high on drugmakers’ radars after the success of Summit ...
The collaboration with Merck KGaA, Darmstadt, Germany focuses on discovering ... including with respect to the progress and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback